Vol 70, No 6 (2019)
Clinical vignette
Published online: 2019-10-23
Excess weight loss in a patient with type 2 diabetes mellitus treated with an SGLT-2 inhibitor
1
, 1
, 1
Abstract
Not available
Keywords: weight lossdiabetesSGLT-2 inhibitor
References
- Diabetology C. 2018 Guidelines on the management of diabetic patients. A position of Diabetes Poland. Clin Diabet. 2018; 7(1): 1–90.
- Chao EC. SGLT-2 Inhibitors: A New Mechanism for Glycemic Control. Clin Diabetes. 2014; 32(1): 4–11.
- Cai X, Yang W, Gao X, et al. The Association Between the Dosage of SGLT2 Inhibitor and Weight Reduction in Type 2 Diabetes Patients: A Meta-Analysis. Obesity (Silver Spring). 2018; 26(1): 70–80.
- Thewjitcharoen Y, Yenseung N, Malidaeng A, et al. Effectiveness of long-term treatment with SGLT2 inhibitors: real-world evidence from a specialized diabetes center. Diabetol Metab Syndr. 2017; 9: 96.
- Ferrannini G, Hach T, Crowe S, et al. Energy Balance After Sodium-Glucose Cotransporter 2 Inhibition. Diabetes Care. 2015; 38(9): 1730–1735.
